Please login to the form below
Portugal
This page shows the latest Portugal news and features for those working in and with pharma, biotech and healthcare.
Merck shares positive results for Keytruda in early-stage breast cancer
of the trial and director of the Breast Unit of the Champalimaud Clinical Centre in Portugal.
Latest news
-
GSK’s five-in-one meningococcal vaccine candidate shows promise in phase 3 trial
Preliminary results for the MenABCWY candidate were presented by the company at the European Society for Paediatric Infectious Diseases congress in Lisbon, Portugal.
-
Shire files dry eye drug lifitegrast in Europe
Rather than submitting the marketing application to the EMA, Shire has filed lifitegrast using the decentralised procedure (DCP) to Denmark, Norway, Sweden, Finland, the UK, Germany, the Netherlands, France, Italy, Portugal,
-
Most of the EU would like to host the EMA
Milan (Italy). Porto (Portugal). Sofia (Bulgaria). Stockholm (Sweden). Malta (Malta). Vienna (Austria).
-
Bial launches video campaign for World Parkinson’s Day
Aims to challenge negative portrayals of people with the disease. Portugal-based pharma company Bial has launched a video campaign, ‘Me At My Best’, to raise awareness of Parkinson’s disease.
-
Type 2 diabetes can be reversed in just four months, say researchers
had diabetes in 2014 – with the highest levels in Greece, Portugal and France – and that the disease cost around 100bn in 2013.
More from news
Approximately 0 fully matching, plus 67 partially matching documents found.
Latest Intelligence
-
Piloting a route to the biosimilars opportunities in Europe
After the introduction of biosimilars in Portugal for erythropoietin (EPO), a hormone produced by the kidneys to stimulate production and maintenance of crucial red blood cells, the originator product was reduced
-
The sound of silence puts the squeeze on generics and biosimilars
landscape. “Where we see the challenge is where government-mandated price cuts are imposed without discussion or compensation over volume and we have seen that in recent years in Portugal, France
-
Market access improvements in Turkey
Italy, Portugal and Spain plus the country of origin).
-
Challenging perceptions
Before relocating for his new role in Switzerland, he spent nearly five years as a business unit director for neuroscience for Spain and Portugal.
-
Case study: Cancer cookbook
To date, more than 20, 000 copies have been distributed across the UK, Portugal, Germany, Austria, Switzerland and Italy.
More from intelligence
Approximately 2 fully matching, plus 12 partially matching documents found.
Latest appointments
-
ClinTec appoints regional manager for Spain and Portugal
Carlos Palacios joins the contract research organisation. Contract research organisation ClinTec International has appointed Carlos Palacios to the newly-created position of regional manager for Spain and Portugal. ... Palacios joins ClinTec from Merck,
-
Former Roche CEO joins BIAL board
Franz Humer to advise Portuguese pharma company. Portugal-based pharma company BIAL has appointed former Roche CEO Franz Humer as a non-executive member of its board.
-
IMI appoints new chair of scientific committee
Portugal’s Maria Beatriz da Silva Lima to join EC’s collaborative research group. ... Prof da Silva Lima (pictured) of the University of Lisbon in Portugal will lead a 12-strogn committee, which provides strategic scientific advice to the IMI – a
-
Tonio Borg nominated to replace John Dalli as EC Health Commissioner
by a representative from Malta until 2014 under the presidency of Portugal's José Manuel Barroso.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role
in Coimbra, Portugal, eight in the United States – Fairfield and Glastonbury, CT, Philadelphia and Wyomissing, PA, Warren, NJ, Boston and Melrose, MA, Powell, OH; and two in the Asia-Pacific region –
-
Award-winning health agency 90TEN launches in the US
Envision has 20 offices: six in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London, Wilmslow, and Alderley Edge; one in Serbia – Subotica; one in Hungary – Szeged; one in Coimbra, Portugal,
-
Key barriers to effective patient engagement in pharma, and how to fix them: Making engagement processes more patient friendly
Merck’s “Embracing carers” initiative as presented by Rita Reis, Head of Communications for Mid-Europe &Portugal.
-
Health literacy in the time of COVID-19
Likewise, a survey conducted in Portugal in late 2020 identified having no intention of taking the flu vaccine and perception of the information provided as inconsistent and contradictory as two key
-
90TEN promotes Claire Long and Sabrina Gomersall to lead Communications division
in Coimbra, Portugal, eight in the United States – Fairfield and Glastonbury, CT, Philadelphia and Wyomissing, PA, Warren, NJ, Boston and Melrose, MA, Powell, OH; and two in the Asia-Pacific region –
More from PMHub
Approximately 0 fully matching, plus 15 partially matching documents found.
Subscribe to our email news alerts
- Pfizer’s RSV vaccine granted MHRA approval to protect infants and older adults
- Novavax’s updated COVID-19 vaccine granted Emergency Use Listing by WHO
- FDA to investigate risk of T-cell malignancy from CAR-T cell immunotherapies
- Boehringer Ingelheim and IBM announce AI antibody drug discovery partnership
- New blood test to reduce heart attacks and death rates in A&E heart patients
- Clairvoyant commercialisation
No results were found
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
- The rise of digital healthcare – fuelled by open innovation in healthtech hubs
- How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development...
